Amgen Inc.
32 drugs in NADAC|0 Generic,32 Brand
Amgen Inc. lists 32 NDCs in the CMS NADAC file (0 generic, 32 brand), at an average NADAC of $875.44 per unit, with a week-over-week move of -0.1% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
32
0G / 32B
Avg Price / Unit
$875.4439
$9.98 – $10074.86
Avg 7d Change
-0.06%
Across 16 drugs with changes
7d Activity
of 32 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Frequently Asked Questions
How many drugs does Amgen Inc. make?
Amgen Inc. lists 32 NDCs in the CMS NADAC file — 0 generic and 32 brand products.
What is the average price of Amgen Inc. drugs?
The average NADAC across Amgen Inc.'s portfolio is $875.4439 per unit, ranging from $9.9806 to $10074.8571.
What types of drugs does Amgen Inc. make?
Amgen Inc. makes drugs across 7 FDA pharmacologic classes. The most common by NDC count are Erythropoiesis-stimulating Agent (9), Leukocyte Growth Factor (5), RANK Ligand Inhibitor (4), PCSK9 Inhibitor (4), Calcium-sensing Receptor Agonist (3).
Has Amgen Inc. had any drug recalls?
No FDA enforcement recalls are matched to Amgen Inc. in the openFDA feed.
How has Amgen Inc.'s pricing changed recently?
Over the past 7 days, 4 Amgen Inc. products rose and 12 fell, with a portfolio-wide average change of -0.1%.